Absorbed doses in the marrow during131I therapy
- 1 May 1977
- journal article
- research article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 50 (593) , 329-331
- https://doi.org/10.1259/0007-1285-50-593-329
Abstract
Absorbed doses to red marrow and blood from 131I therapy were reevaluated using data which became available recently. Uncertainties in the calculations are discussed and a comparison is made with previously published dose estimates. The mean dose to red marrow from the treatment of [human] hyperthyroidism is estimated to be 0.59 rad mCi-1, compared with 0.36 rad mCi-1 for the euthyroid state. [Leukemia incidence in 131I treated hyperthyroid or carcinoma patients is discussed.].This publication has 7 references indexed in Scilit:
- The absorbed dose to bone marrow in the treatment of polycythaemla by32PThe British Journal of Radiology, 1976
- Protection problems in radionuclide therapy: the patient as a gamma-radiation sourceThe British Journal of Radiology, 1975
- Dosimetry of radionuclides in bloodThe British Journal of Radiology, 1974
- Incidence of Leukemia Following Treatment of HyperthyroidismPublished by American Medical Association (AMA) ,1968
- Blood Radiation Dose After 131I Therapy of ThyrotoxicosisBMJ, 1961
- Calculation of Radioactive Iodine Beta Radiation Dose to the Bone MarrowThe British Journal of Radiology, 1954
- THE DISTRIBUTION OF RADIOACTIVE IODINE IN HUMAN TISSUES: NECROPSY STUDY IN NINE PATIENTS*Journal of Clinical Endocrinology & Metabolism, 1950